PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in PharmaCyte Biotech, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q1 2023
- Shares held
- 1.21M
- −2.31M (−65.6%) vs. Q1 2023
- Total value
- $3.47M
- −$6.75M (−66.1%) vs. Q1 2023
- New holders
- 6
- 3 more added
- Sold out
- 7
- 13 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 98 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $3 | 0.00% | +1 | New |
| GWM Advisors LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 2 | $6 | 0.00% | +2 | New |
| UBS Group AG | 9 | $25 | 0.00% | −1,679−99.5% | Reduced |
| Morgan Stanley | 21 | $60 | 0.00% | −10−32.3% | Reduced |
| Anchor Investment Management, LLC | 27 | $77 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 54 | $154 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 185 | $529 | 0.00% | +56+43.4% | Added |
| Kelly Financial Services LLC | 234 | $669 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 189 | $1.00K | 0.00% | +189 | New |
| Aspire Private Capital, LLC | 800 | $2.29K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 954 | $3.00K | 0.00% | +953+95,300.0% | Added |
| Advisor Group Holdings, Inc. | 1,758 | $5.03K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 7,126 | $20.0K | 0.00% | −2,138−23.1% | Reduced |
| CSS LLC | 13,186 | $37.7K | 0.00% | +13,186 | New |
| Group One Trading, L.P. | 14,282 | $40.8K | 0.00% | −100−0.7% | Reduced |
| Bank of New York Mellon Corp | 16,593 | $47.5K | 0.00% | +16,593 | New |
| Schonfeld Strategic Advisors LLC | 23,500 | $67.2K | 0.00% | −500−2.1% | Reduced |
| Renaissance Technologies LLC | 25,874 | $74.0K | 0.00% | +25,874 | New |
| Northern Trust Corp | 28,415 | $81.3K | 0.00% | −833−2.8% | Reduced |
| Dimensional Fund Advisors LP | 29,303 | $83.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 43,318 | $123.9K | 0.00% | −393−0.9% | Reduced |
| Simplex Trading, LLC | 47,149 | $134.0K | 0.01% | −86,051−64.6% | Reduced |
| Equitec Proprietary Markets, LLC | 61,415 | $175.6K | 0.12% | −269,279−81.4% | Reduced |
| Citadel Advisors LLC | 64,908 | $185.6K | 0.00% | −11,103−14.6% | Reduced |
| K2 Principal Fund, L.P. | 154,232 | $441.1K | 0.14% | −569,039−78.7% | Reduced |
| Vanguard Group Inc | 183,582 | $525.0K | 0.00% | −517,868−73.8% | Reduced |
| Geode Capital Management, LLC | 219,074 | $626.6K | 0.00% | +43,810+25.0% | Added |
| Ayrton Capital LLC | 276,992 | $792.2K | 4.95% | −753,538−73.1% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −106,886−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −62,600−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −7,135−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −505−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |